HAGAR Announces Preliminary Results of Study For Its Non Invasive Glucose Monitoring System

Status
Not open for further replies.
This is the only published study I find on a quick look. Small pilot, from 2021. (Maybe there will be a publication at some point for the study described in this PR.)


No idea how far away from being an actual product this might be with whatver reg approvals but at a guess it would be a big long effort & lots of $$$ to get it out of the lab & into the market. I get the impression their strategy is to get a solid preclinical pack together for a sale to some big player to do the real clinical rials & commercialise it.

Raising a Series C round to that end, having raised ~$16M in Series A and B rounds so far. They do not have a name-brand VC backer so far - why not? Maybe they are far enough along to attract one or a real strategic investor for the C round. The management team looks gappy for medical device reg/commercialisation experience - mainly defence electronics - though the board seem to have some relevant experience.
 
Last edited:
Why does it look like Non Invasive monitors are just around the corner?
Because many people like yourself want to believe it and these "teasers" probably generate investment for the developers.
 
Status
Not open for further replies.
Back
Top